Product Research

New Study Proves Effectiveness of ZICAM in people who begin treatment within first 2 days of illness

New research conducted by the Cleveland Clinic Foundation, one of the world's largest and most prestigious health centers, again confirms the efficacy of Zicam Cold Remedy. This clinical study demonstrated that Zicam reduced the severity and duration of common cold symptoms even when treatment is started as late as the second day after onset of illness. The study appeared in the January 2003 issue of QJM: An International Journal of Medicine.

This research is important because it demonstrates that Zicam can still reduce the duration of the common cold even when busy cold sufferers can't or don't start using Zicam within the first 24 hours of illness. Previous research studies all initiated treatment within the first 24 hours of symptoms.

For Full Study Click Here (PDF 112 KB)

Zinc nasal gel for the treatment of common cold symptoms: A double-blind, placebo-controlled trial

The common cold is caused by a viral infection in the nose. Its symptoms, which vary in severity, include sneezing, rhinorrhea, nasal congestion, sore and/or scratchy throat, cough, hoarseness, and mild general symptoms such as headache, fever, and body aches. Of the more than 100 different cold viruses, the most important are rhinoviruses. The lack of effective treatments for the common cold is of concern because adults contract an average of approximately three colds each year, and children experience twice as many. The number of work days lost to cold-related illness is substantial.

For Full Study Click Here (PDF 27 KB)

Daily Application Of The Homeopathic Remedy Zicam Allergy Relief Significantly Improves The Quality Of Life And Impairment In Patients With Seasonal Allergic Rhinitis

For Full Study Click Here (PDF 256 KB)